Skip to main content
. 2024 May 14;24:587. doi: 10.1186/s12885-024-12316-4

Fig. 5.

Fig. 5

Oxaliplatin and YAP/TAZ drugs interactions in p53 mutant CRC cell lines. A-D HCT116 p53mut (A), HT-29 (B), SW480 (C), and Caco-2 (D) cells were incubated with increasing concentrations of oxaliplatin and either Verteporfin or CA3. Cell viability was assessed with the SRB assay in 2D to obtain the viability matrix. The synergy matrices were calculated as described in “Materials and methods” section